Despite these limitations, our study is, to our knowledge, the first to integrate large‐scale database analysis with clinical sample validation to characterize ASF1B in breast cancer, especially its link to HER2 biology and immune infiltration. The gene discussed is ERBB2; the disease is breast cancer.